iC9.CAR-CSPG4 T cells
/ Bellicum, UNC Lineberger Comprehensive Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 23, 2024
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
(clinicaltrials.gov)
- P1/2 | N=33 | Recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center | Not yet recruiting ➔ Recruiting
CAR T-Cell Therapy • Enrollment open • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • CSPG4
January 23, 2024
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
(clinicaltrials.gov)
- P1/2 | N=33 | Not yet recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center | Initiation date: Dec 2023 ➔ Mar 2024
CAR T-Cell Therapy • Trial initiation date • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • CSPG4
October 23, 2023
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
(clinicaltrials.gov)
- P1/2 | N=33 | Not yet recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center
CAR T-Cell Therapy • New P1/2 trial • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • CSPG4
1 to 3
Of
3
Go to page
1